25 October 2018 - Symbicort, an inhaler marketed to people whose lung disease makes them “huff and puff,” rolls off the manufacturing line at a price of $327 for a month’s supply.

A familiar TV ad, in which a little girl compares her grandfather’s cough to the Big Bad Wolf from “The Three Little Pigs,” trumpets the drug’s benefits and advises about side effects but doesn’t mention the list price.

That could change under the Trump administration’s proposed rules that would require companies to disclose the cost in legible print on any video ads.

Read Washington Times article